Drug suppliers’ stocks jump as Amazon retreats from drug distribution

 Many U.S. drug suppliers saw their stock prices rise April 16 following the news Amazon dropped its plan to sell and distribute pharmaceutical products to hospitals, reports Reuters.

Advertisement

McKesson, AmerisourceBergen and Cardinal Health’s stock each increased 2 to 3 percent April 16. Walgreens Boots Alliance and CVS Health’s stock both jumped about 5 percent.

Amazon’s retreat from drug distribution stems from its inability to convince hospitals to follow different purchasing processes for pharmaceuticals, unnamed sources told CNBC. Instead, the Amazon Business unit will focus on selling less sensitive medical supplies to smaller hospitals and clinics.

Amazon declined Reuters‘ request for comment.

More articles on supply chain:
Bloomberg: Why generic medications may disappear
Taking the Operating Room Supply Chain Processes from ‘Necessary Evil’ to ‘Essential Ally’
High drug prices worry 83% of Americans: This is CVS’ new solution

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.